Clinical trial
Study to Evaluate Potential Decrease in Hospitalization Events, Time Between…
NCT00090259 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00090259 |
|---|---|
| Title | Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948) |
| Official title | A Multi-center, Double-Blind, Randomized, Parallel Group Study to Evaluate the Effects of Two Different Doses of Losartan on Morbidity and Mortality in Patients With Symptomatic Heart Failure Intolerant of ACE Inhibitor Treatment |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Failure |
| Intervention type | Drug |
| Interventions | Losartan 50 mg, Losartan 150 mg |
| Enrollment | 3,834 |
| Start date | Dec 19, 2001 |
| Primary completion | Mar 31, 2009 |
| Completion | May 13, 2009 |
| First posted | Aug 27, 2004 |
| Last update posted | May 16, 2024 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: